• Mentor (Santa Barbara, California) reported FDA approval of its Prevelle Silk, which it calls the first of a new line of lidocaine containing hyaluronic acid (HA) dermal fillers. Prevelle Silk is a colorless HA gel with lidocaine that is injected into facial skin to reduce moderate to severe facial lines, folds, and wrinkles. It is indicated for injection into the mid–to–deep dermis for correction of moderate–to–severe facial wrinkles and folds (such as nasolabial folds). Mentor makes aesthetic products.

• ReBuilder Medical Technologies (RBRM; Charleston, West Virginia) reported completion of the development cycle of its highly secreted electronic treatment system for Molluscum Contagiosum. "We have been successfully treating Molluscum with our proprietary nano–silver ointment for the past four years," said David Phillips, PhD, president of RBRM. "Although it has been the only painless treatment, it can take from three weeks to three months to achieve complete remission; now patients can begin to see success in as little as threee days." RBRM makes electronic devices for diabetic peripheral neuropathy, Molluscum contagiosum and MRSA.